Essure Permanent Birth Control | FDA

Essure Permanent Birth Control | FDA

FDA Provides Updates on Ongoing Postmarket Activities For Essure Device

Today, the U.S Food and Drug Administration (FDA) is providing an update on the discontinuation of Essure and our ongoing postmarket activities.  As of December 31, 2019, all unused Essure devices should have been returned to Bayer so that they are no longer available for implantation.  Women who have been using Essure successfully to prevent pregnancy can and should continue to do so.

Read More